a-connect

Discover how we led the successful integration of two global pharmaceutical companies on schedule and with zero disruption and no interruptions to patient supply chains. #management #consultancy #independentconsultancy #pharma #pharmaceutical #merger #acquisition #integration #supplychain https://lnkd.in/g_waajWm

Driven by EU support and environmental concerns, biostimulants enhance  plant growth, development, and stress tolerance. As the second-largest segment in Ag biologicals, it’s time to consider adding them to your product portfolio. #agribusiness #biostimulants #productportfolio https://lnkd.in/eN_Q6u7E

The a-connect team is thrilled to be attending Vitafoods Europe 2024 in Geneva! One of the highlights for us at Vitafoods is the opportunity to meet clients from the food, nutrition, and ingredient sectors face-to-face in an exciting environment. We look forward to exploring the halls of Palexpo and immersing ourselves in the latest industry trends and innovations. Join us on May 14 & 15 to connect, share insights, and discuss the evolving industry landscape. #vitafoodseurope #nutritioninnovation #foodconsulting #consultancythatdelivers https://lnkd.in/dVzY2cUM

Navigating the post-Loss of Exclusivity (LoE) landscape demands a strategic shift. Dr. Martin Kamleiter-Borski, Client Service Partner at a-connect’s Life Sciences Practice, explains the need for a new mindset and playbook in defending against generics and biosimilars. #lifesciences #lossofexclusivity #sustainingrevenue https://lnkd.in/eHQdWMVG

In today's dynamic digital landscape, small to mid-sized pharmaceutical companies have distinct opportunities. Dr. Martin Kamleiter-Borski, Life Sciences Client Service Partner with a-connect, outlines four essential steps towards achieving Omnichannel Excellence. #lifesciences #omnichannel #digitallandscape https://lnkd.in/e9rga8Dp

Delivering sales excellence is no easy feat, let alone when you’re operating across multiple diverse countries. Here’s how we applied our expertise for our client in private equity. #privateequity #culturaladaptation #organizationalgovernence #strategy https://lnkd.in/ejK3ChJb

Entering the post-Loss of Exclusivity (LoE) zone is a complete game changer in terms of strategy and approach because you are often immediately fending against generics and biosimilars. So, how do you sustain revenue streams and volume with the newfound competition? #lifesciences #lossofexclusivity #sustainingrevenue https://lnkd.in/eHQdWMVG

In light of #EarthDay 2024, let’s remind ourselves of the ways to deliver sustainability strategies in a world of conflicting demands. #agribusiness  #sustainabilitystrategies https://lnkd.in/e8dEHjpe

In a world focused on soil preservation, reduced emissions, and biodiversity impact, how can we also successfully meet the demand for food production and, of course, economic targets? #agribusiness #soilpreservation #carbonemissions #biodiversity https://lnkd.in/e8dEHjpe

The dynamic digital world is reshaping the pharmaceutical industry, offering distinct possibilities for small to mid-sized pharmaceutical firms. The crucial aspect lies in forging genuine omnichannel connectivity. Here are the four steps that you can take to get there. #lifesciences #pharmaceuticals #omnichannel https://lnkd.in/e9rga8Dp